| Bioactivity | CPI-0610 carboxylic acid is a ligand for target protein for PROTACT. CPI-0610 carboxylic acid is a potent bromodomain and extra-terminal (BET) protein inhibitor. CPI-0610 carboxylic acid has the potential in the therapy of multiple myeloma[1]. |
| Target | BET |
| CAS | 1380089-81-5 |
| Formula | C20H15ClN2O3 |
| Molar Mass | 366.80 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Albrecht BK, et al. Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials. J Med Chem. 2016 Feb 25;59(4):1330-9. |
CPI-0610 carboxylic acid
CAS: 1380089-81-5 F: C20H15ClN2O3 W: 366.80
CPI-0610 carboxylic acid is a ligand for target protein for PROTACT. CPI-0610 carboxylic acid is a potent bromodomain an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.